Skip to main content

MoneyWorks4Me

GlaxosmithKline Pharmaceuticals informs about certificate

05 Apr 2021 Evaluate

In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, GlaxosmithKline Pharmaceuticals has informed that it has enclosed a copy of the Certificate received from Kfintech, the Registrar and share Transfer Agent of the Company, for the quarter ended 31st March 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..